EA200970486A1 - Соединения для ингибирования митоза - Google Patents

Соединения для ингибирования митоза

Info

Publication number
EA200970486A1
EA200970486A1 EA200970486A EA200970486A EA200970486A1 EA 200970486 A1 EA200970486 A1 EA 200970486A1 EA 200970486 A EA200970486 A EA 200970486A EA 200970486 A EA200970486 A EA 200970486A EA 200970486 A1 EA200970486 A1 EA 200970486A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
mytoze
inhibition
methods
present
Prior art date
Application number
EA200970486A
Other languages
English (en)
Other versions
EA015779B1 (ru
Inventor
Кристофер Ф. Клэйборн
Тодд Б. Селлс
Стефен Г. Страуд
Original Assignee
Милленниум Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39315133&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200970486(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Милленниум Фармасьютикалз, Инк. filed Critical Милленниум Фармасьютикалз, Инк.
Publication of EA200970486A1 publication Critical patent/EA200970486A1/ru
Publication of EA015779B1 publication Critical patent/EA015779B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Настоящее изобретение относится к соединениям формулы (I) и к способам лечения рака. В частности, настоящее изобретение предусматривает активные ингибиторы Aurora А киназы, фармацевтические композиции, содержащие эти соединения, и способы применения соединений для лечения рака.
EA200970486A 2006-11-16 2007-11-14 Соединения для ингибирования митоза EA015779B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85934006P 2006-11-16 2006-11-16
PCT/US2007/023948 WO2008063525A1 (en) 2006-11-16 2007-11-14 Compounds for inhibiting mitotic progression

Publications (2)

Publication Number Publication Date
EA200970486A1 true EA200970486A1 (ru) 2009-10-30
EA015779B1 EA015779B1 (ru) 2011-12-30

Family

ID=39315133

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200970486A EA015779B1 (ru) 2006-11-16 2007-11-14 Соединения для ингибирования митоза

Country Status (35)

Country Link
US (6) US8026246B2 (ru)
EP (4) EP2086981B1 (ru)
JP (3) JP5102839B2 (ru)
KR (2) KR101342014B1 (ru)
CN (2) CN101547924B (ru)
AR (1) AR064246A1 (ru)
AT (1) ATE556076T1 (ru)
AU (1) AU2007322046B2 (ru)
BR (1) BRPI0718803B8 (ru)
CA (1) CA2669680C (ru)
CL (1) CL2007003244A1 (ru)
CR (3) CR10782A (ru)
CY (1) CY1112828T1 (ru)
DK (2) DK2497772T3 (ru)
EA (1) EA015779B1 (ru)
ES (3) ES2384123T3 (ru)
GE (1) GEP20125459B (ru)
HK (4) HK1134672A1 (ru)
HR (2) HRP20120490T1 (ru)
IL (1) IL198690A0 (ru)
MA (1) MA30988B1 (ru)
MX (3) MX348568B (ru)
MY (1) MY153243A (ru)
NO (1) NO343338B1 (ru)
NZ (3) NZ577042A (ru)
PH (1) PH12012502057A1 (ru)
PL (2) PL2086981T3 (ru)
PT (2) PT2497772E (ru)
RS (2) RS52313B (ru)
SG (2) SG10201503350TA (ru)
SI (2) SI2497772T1 (ru)
TW (1) TWI401255B (ru)
UA (1) UA94129C2 (ru)
WO (1) WO2008063525A1 (ru)
ZA (1) ZA200903279B (ru)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005243175B2 (en) * 2004-05-14 2011-12-01 Millennium Pharmaceuticals, Inc. Compounds and methods for inhibiting mitotic progression by inhibition of Aurora kinase
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
EP2373657B1 (en) * 2008-12-05 2016-09-14 Millennium Pharmaceuticals, Inc. 5,7-dihydro-6h-pyrimido[5,4-d][1]benzazepin-6-thiones as plk inhibitors
US20100183601A1 (en) * 2008-12-22 2010-07-22 Millennium Pharmaceuticals, Inc. Combination of Aurora Kinase Inhibitors and Anti-CD20 Antibodies
JO3635B1 (ar) * 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
JO3434B1 (ar) 2009-07-31 2019-10-20 Millennium Pharm Inc مركبات صيدلانية لمعالجة السرطان وامراض واضطرابات اخري
JP2013520424A (ja) * 2010-02-19 2013-06-06 ミレニアム ファーマシューティカルズ， インコーポレイテッド ナトリウム４−｛［９−クロロ−７−（２−フルオロ−６−メトキシフェニル）−５Ｈ−ピリミド［５，４−ｄ］［２］ベンゾアゼピン−２−イル］アミノ｝−２−メトキシベンゾエートの結晶形
US20120107304A1 (en) 2010-04-27 2012-05-03 Boehringer Ingelheim International Gmbh Combination therapy in treatment of oncological and fibrotic diseases
EP2585465B1 (en) * 2010-06-22 2014-11-12 GlaxoSmithKline LLC Benzotriazolodiazepine compounds inhibitors of bromodomains
UY34114A (es) 2011-06-03 2013-01-03 Millennium Pharm Inc Combinación de inhibidores de mek e inhibidores selectivos de la quiinasa aurora a
US20130303519A1 (en) * 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
CN103772391A (zh) * 2012-10-23 2014-05-07 杨子娇 一类治疗房角狭窄的化合物及其用途
CN105209042B (zh) * 2013-03-22 2019-03-08 米伦纽姆医药公司 催化性mtorc 1/2抑制剂与选择性极光a激酶抑制剂的组合
JP6525474B2 (ja) 2013-12-06 2019-06-05 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． オーロラキナーゼ阻害剤と抗ｃｄ３０抗体の併用
US20180263979A1 (en) * 2014-12-23 2018-09-20 Millennium Pharmaceuticals, Inc. Combination of raf inhibitors and aurora kinase inhibitors
CA2997769A1 (en) 2015-09-09 2017-03-16 Icahn School Of Medicine At Mount Sinai Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents
CA2997784A1 (en) 2015-09-09 2017-03-16 Icahn School Of Medicine At Mount Sinai Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents
JP6591036B2 (ja) 2016-02-26 2019-10-16 公益財団法人がん研究会 Ｈｐ１の機能に着目した抗癌剤のスクリーニング方法及び評価系
EA201892075A1 (ru) 2016-03-15 2019-04-30 Оризон Дженомикс, С.А. Комбинации ингибиторов lsd1 для применения для лечения солидных опухолей
JP6188986B1 (ja) * 2017-03-23 2017-08-30 株式会社ノエビア 時計遺伝子発現量調整剤及びエラスチン産生促進剤
WO2019195658A1 (en) 2018-04-05 2019-10-10 Dana-Farber Cancer Institute, Inc. Sting levels as a biomarker for cancer immunotherapy
WO2020049208A1 (es) 2018-09-09 2020-03-12 Fundacio Privada Institut De Recerca De La Sida - Caixa Aurora cinasa como diana para tratar, prevenir o curar una infección por vih o sida
WO2021041532A1 (en) 2019-08-26 2021-03-04 Dana-Farber Cancer Institute, Inc. Use of heparin to promote type 1 interferon signaling
WO2023196959A1 (en) 2022-04-07 2023-10-12 Eli Lilly And Company Process for making a kras g12c inhibitor
WO2023196887A1 (en) 2022-04-08 2023-10-12 Eli Lilly And Company Method of treatment including kras g12c inhibitors and aurora a inhibitors
WO2024006424A1 (en) 2022-06-30 2024-01-04 Eli Lilly And Company Kras g12c inhibitor for treating cancer

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4099012A (en) * 1975-08-28 1978-07-04 Ciba-Geigy Corporation 2-pyrazolyl-benzophenones
SU1181547A3 (ru) 1979-02-07 1985-09-23 Ф.Хоффманн-Ля Рош Унд Ко,Аг (Фирма) Способ получени пиримидо-2-бензазепинов или их фармакологически совместимых кислотно-аддитивных солей (и его вариант)
US4481142A (en) * 1979-02-07 1984-11-06 Hoffmann-La Roche Inc. Pyrimido-2-benzazepines
US4469633A (en) * 1980-05-16 1984-09-04 Hoffmann-La Roche Inc. N-oxides of 5-oxo-1-phenyl-2-benzazepines
EP0273697A3 (en) 1986-12-30 1989-11-29 Merck & Co. Inc. 2-benzazepines with 5- and 6- membered heterocyclic rings
US5166151A (en) * 1988-03-25 1992-11-24 Merck & Co., Inc. 2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof
US5210082A (en) * 1991-05-16 1993-05-11 Merck & Co., Inc. 2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders
GB9523675D0 (en) 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
US6124281A (en) 1996-03-08 2000-09-26 Zeneca Limited Azolobenzazepine derivatives as neurologically active agents
JP2001507349A (ja) * 1996-12-23 2001-06-05 セルテック セラピューティックス リミテッド 縮合多環式２−アミノピリミジン誘導体、それらの製造およびたんぱく質チロシンキナーゼ抑制因子としてのそれらの使用
GB9713087D0 (en) 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
ID24101A (id) 1997-09-29 2000-07-06 Meiji Seika Kaisha Turunan-turunan triazolobenzazepine trisiklik, proses pembuatan yang sama, dan zat-zat antialergi
US6277844B1 (en) * 1998-09-14 2001-08-21 Sydney Spector Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
AU1651201A (en) 1999-12-06 2001-06-18 Ajinomoto Co., Inc. Amidinophenylpyruvic acid derivative
BR0116411A (pt) 2000-12-21 2003-11-11 Vertex Pharma Compostos de pirazol úteis como inibidores de proteìna cinase
US6686352B2 (en) 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
DE10135457A1 (de) * 2001-07-20 2003-02-06 Adc Automotive Dist Control Optische Sensoranordnung
IL159963A0 (en) 2001-08-09 2004-06-20 Actelion Pharmaceuticals Ltd Novel benzo-fused heterocycles as endothelin antagonisits
CN1897950A (zh) 2003-10-14 2007-01-17 惠氏公司 稠合芳基和杂芳基衍生物及其使用方法
AU2005243175B2 (en) 2004-05-14 2011-12-01 Millennium Pharmaceuticals, Inc. Compounds and methods for inhibiting mitotic progression by inhibition of Aurora kinase
EP1812424A4 (en) 2004-11-17 2009-07-08 Miikana Therapeutics Inc Kinase Inhibitors
US20100160324A1 (en) 2004-12-30 2010-06-24 Astex Therapeutics Limited Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
KR20080083680A (ko) 2005-12-23 2008-09-18 스미스클라인 비참 코포레이션 오로라 키나제의 아자인돌 억제제
EP2054413A2 (en) 2006-08-09 2009-05-06 Millennium Pharmaceuticals, Inc. Pyridobenzazepine compounds and methods for inhibiting mitotic progression
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها

Also Published As

Publication number Publication date
SG10201503350TA (en) 2015-06-29
DK2497772T3 (en) 2015-01-19
US20080167292A1 (en) 2008-07-10
MX348568B (es) 2017-06-20
HK1217699A1 (zh) 2017-01-20
WO2008063525A1 (en) 2008-05-29
EP2944639B1 (en) 2017-01-04
HRP20150047T1 (en) 2015-03-13
HK1134672A1 (en) 2010-05-07
HK1175778A1 (en) 2013-07-12
CA2669680A1 (en) 2008-05-29
SI2497772T1 (sl) 2015-03-31
HRP20120490T1 (hr) 2012-07-31
MX2009004670A (es) 2009-05-15
PT2086981E (pt) 2012-06-20
EP2944639A1 (en) 2015-11-18
CR20140154A (es) 2014-07-23
PH12012502057B1 (en) 2015-09-14
MX343391B (es) 2016-11-04
JP5452811B2 (ja) 2014-03-26
US11958855B2 (en) 2024-04-16
MA30988B1 (fr) 2009-12-01
EP2086981B1 (en) 2012-05-02
US8026246B2 (en) 2011-09-27
CN103483343B (zh) 2016-06-01
AU2007322046A1 (en) 2008-05-29
JP2012006965A (ja) 2012-01-12
BRPI0718803B1 (pt) 2020-11-17
BRPI0718803A2 (pt) 2013-12-03
NO20091864L (no) 2009-06-15
US20190031662A1 (en) 2019-01-31
IL198690A0 (en) 2010-02-17
ATE556076T1 (de) 2012-05-15
TW200829589A (en) 2008-07-16
CA2669680C (en) 2012-04-10
UA94129C2 (ru) 2011-04-11
CN101547924B (zh) 2013-09-25
EA015779B1 (ru) 2011-12-30
RS53788B1 (en) 2015-06-30
US20110312942A1 (en) 2011-12-22
KR20110113210A (ko) 2011-10-14
KR101342014B1 (ko) 2013-12-19
EP2497772B1 (en) 2014-10-29
EP2086981A1 (en) 2009-08-12
PL2497772T3 (pl) 2015-05-29
US20110312943A1 (en) 2011-12-22
KR101110458B1 (ko) 2012-03-13
EP2497773A1 (en) 2012-09-12
CR20140544A (es) 2015-01-12
JP2010510215A (ja) 2010-04-02
EP2497772A1 (en) 2012-09-12
SG176443A1 (en) 2011-12-29
US10836766B2 (en) 2020-11-17
NZ611898A (en) 2015-01-30
JP2014055166A (ja) 2014-03-27
US20210214361A1 (en) 2021-07-15
PH12012502057A1 (en) 2015-09-14
GEP20125459B (en) 2012-03-26
US20150166545A1 (en) 2015-06-18
AR064246A1 (es) 2009-03-25
NZ597252A (en) 2013-06-28
EP2497773B1 (en) 2015-02-25
ES2384123T3 (es) 2012-06-29
NZ577042A (en) 2012-03-30
CL2007003244A1 (es) 2008-04-04
ES2537451T3 (es) 2015-06-08
RS52313B (en) 2012-12-31
MY153243A (en) 2015-01-29
CY1112828T1 (el) 2016-02-10
KR20090091173A (ko) 2009-08-26
DK2086981T3 (da) 2012-08-06
HK1175777A1 (en) 2013-07-12
US9765076B2 (en) 2017-09-19
CN101547924A (zh) 2009-09-30
PL2086981T3 (pl) 2012-09-28
US9988384B2 (en) 2018-06-05
PT2497772E (pt) 2015-02-05
BRPI0718803B8 (pt) 2021-05-25
NO343338B1 (no) 2019-02-04
CR10782A (es) 2009-06-24
TWI401255B (zh) 2013-07-11
SI2086981T1 (sl) 2012-12-31
AU2007322046B2 (en) 2012-04-05
JP5102839B2 (ja) 2012-12-19
ES2528793T3 (es) 2015-02-12
CN103483343A (zh) 2014-01-01
ZA200903279B (en) 2010-07-28

Similar Documents

Publication Publication Date Title
EA200970486A1 (ru) Соединения для ингибирования митоза
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
NO20065148L (no) Monocykliske heterocykler som kinase inhibitorer
EA201291356A1 (ru) Пиперидиноновые производные как ингибиторы mdm2 для лечения рака
EA200970156A1 (ru) Пиридизиноновые производные
EA201290183A1 (ru) Бензодиазепиновый ингибитор бромодомена
DK1853602T3 (da) Kemiske forbindelser
DK1853588T3 (da) Kemiske forbindelser
EA200701257A1 (ru) Пирролопиразолы в качестве сильнодействующих ингибиторов киназы
EA201101341A1 (ru) Соединения, ингибирующие киназы, и фармацевтическая композиция на их основе
WO2006123113A3 (en) Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
EA200602100A1 (ru) Соединения и способы для ингибирования митотической прогрессии
EA200700192A1 (ru) Производные фталазина в качестве ингибиторов parp
EA200970680A1 (ru) N-замещенные производные глицина: ингибиторы гидроксилаз
EA200870415A1 (ru) Хиназолины для ингибирования pdk 1
ATE549336T1 (de) Heteroarylverbindungen,zusammensetzungen daraus und ihre verwendung als proteinkinasehemmer
EA200801041A1 (ru) Ингибиторы мек и способы их применения
EA200700189A1 (ru) Производные хиназолина в качестве ингибиторов parp
EA200970542A1 (ru) ИНГИБИТОРЫ ДЕЙСТВИЯ Akt
EA200800374A1 (ru) 1,4-дигидропиридин-конденсированные гетероциклы, способы их получения, применение и содержащие их композиции
UA85087C2 (en) Monocyclic heterocycles as kinase inhibitors
EA201070442A1 (ru) НОВЫЕ ИНГИБИТОРЫ sEH И ИХ ПРИМЕНЕНИЕ
MX2009012079A (es) Compuestos heterociclicos condensados como inhibidores de proteina cinasas.
EA200970361A1 (ru) Ингибиторы киназы
TW200602023A (en) Monocyclic heterocycles as kinase inhibitors